Pyridostigmine Bromide 180 mg / 1 Tablet 30 Tablet, Extended Release
Comprehensive product details for sourcing and verification.
| NDC 11 | 47781-0335-30 |
|---|---|
| Product NDC | 47781-0335 |
| Generic Drug Name | Pyridostigmine Bromide |
| Brand Name | Pyridostigmine Bromide |
| Manufacturer | Alvogen, Inc. |
| Strength | 180 mg / 1 |
| Dosage Form | Tablet |
| Drug Type | Oral |
| Package Quantity | 30 Tablet, Extended Release |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-335-30) |
| Active Ingredients | Pyridostigmine Bromide |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Pyridostigmine Bromide 180 mg / 1 Tablet is tracked under NDC 47781-0335-30 and rolls up into product family 47781-0335. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 30 Tablet, Extended Release.
- Manufacturer: Alvogen, Inc..
- Dosage form: Tablet.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Pyridostigmine Bromide 180 mg / 1 Tablet 30 Tablet, Extended Release, NDC 47781-0335-30, is a Alvogen, Inc. 180 mg / 1 tablet presentation packaged as 30 Tablet, Extended Release.
NDC search formats
- Canonical NDC 11: 47781-0335-30.
- Digits-only NDC 11: 47781033530.
- Possible 10-digit display format: 47781-335-30 (4778133530).
Helpful product links
- Search by brand name: Pyridostigmine Bromide.
- Exact NDC 11: 47781-0335-30.
- Product family NDC: 47781-0335.
